Pharmacists in Waverly, OH Accepting Medicare

23 Pharmacists found. Showing 1 - 20

Dr. Wenjing Wang, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 E Emmitt Ave, Waverly, OH 45690 Phone: 740-941-3017

Logan Bates, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 E Emmitt Ave, Waverly, OH 45690 Phone: 740-941-3017

Nicholas Bachtel, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 E Emmitt Ave, Waverly, OH 45690 Phone: 740-947-2126    Fax: 740-947-4149

Bruce Alan Felts, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 E Emmitt Ave, Waverly, OH 45690 Phone: 740-941-3017

John Liam Johnson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 James Rd, Waverly, OH 45690 Phone: 740-947-5018

Dr. Azzie Osborne Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Waverly Plz, Waverly, OH 45690 Phone: 740-947-0128

Ms. Teri Lee Varney, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 E Emmitt Ave, Waverly, OH 45690 Phone: 740-947-2126    Fax: 740-947-4149

Abigail E Ison, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 220 Waverly Plz, Waverly, OH 45690 Phone: 740-947-9299    Fax: 740-941-0792

Christopher Salmons, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 E Emmitt Ave, Waverly, OH 45690 Phone: 740-941-3017

Caleb Miller, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 220 Waverly Plz, Waverly, OH 45690 Phone: 740-947-0128

Mrs. Cheryl Sue Smith, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Dawn Ln, Waverly, OH 45690 Phone: 740-947-6377    Fax: 740-947-6301

Jason Loutsenhizer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Dawn Ln, Waverly, OH 45690 Phone: 740-947-6320

Mark Marquez, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Dawn Ln, Waverly, OH 45690 Phone: 740-947-6377

Thomas Bartley Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 E. Emmitt Ave., Waverly, OH 45690 Phone: 740-947-2126

Thomas David Kelley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 990 W Emmitt Ave, Waverly, OH 45690 Phone: 740-947-0300

Richard Magliano, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9329 State Route 220, Waverly, OH 45690 Phone: 740-941-1999

Eric Nicholas Davis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 302 E Emmitt Ave, Waverly, OH 45690 Phone: 740-370-8662

Dr. Melissa Sue Dunham, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 210 E Emmitt Ave, Waverly, OH 45690 Phone: 740-947-2126    Fax: 740-947-4149

Mr. Delbert G Brown, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 James Rd, Waverly, OH 45690 Phone: 740-947-5018

Joshua Wayne Smith, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2181 Us Highway 23, Waverly, OH 45690 Phone: 740-708-6049

News Archive

UCLA School of Nursing selects CytoCore's PadKit Collection Kit for comparative cytology study of cervical cancer

CytoCore Inc., the developer of cost-effective products used in the practice of cytology for the detection and diagnosis of cancer and cancer related diseases, announced today that PadKit® Collection Kit, a transport kit using an intralabial device for the collection of gynecological samples, has been selected by the UCLA School of Nursing as the sample collection system for a comparative cytology study of cervical cancer.

Darapladib drug fails to reduce risk of recurrent major coronary events

In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable angina), use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 (believed to play a role in the development of atherosclerosis) did not reduce the risk of recurrent major coronary events, according to a study published by JAMA.

SironRX completes enrollment in Cohort 1 to study JVS-100 for wound healing, scar prevention

SironRX Therapeutics Inc., a privately-held, clinical-stage biotechnology company developing novel regenerative therapies to prevent scarring and promote dermal wound repair, is pleased to report that it has completed enrollment of patients in Cohort 1 of its placebo-controlled, randomized, dose escalation double-blind clinical study evaluating the safety and efficacy of JVS-100 to reduce scar formation and improve wound healing in patients receiving surgical sternotomy incisions.

IETF announces March as National Essential Tremor Awareness Month

The International Essential Tremor Foundation is proud to announce that the United States House of Representatives formally passed House Resolution 1264 sponsored by Congressman Dennis Moore officially designating the month of March as "National Essential Tremor Awareness Month".

Read more Medical News

› Verified 3 days ago

• 1(current)
• 2